Related Experiment Video
Updated: Jun 3, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Involvement of PI3K/Akt/CREB and redox changes in mitochondrial defect of osteoblastic MC3T3-E1 cells
1Department of Food and Nutrition, Kyung Hee University, 1, Hoegi-Dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea. cheunmi@hanmail.net
Abstract:
Antimycin A (AMA) is an inhibitor of mitochondrial electron transport via its binding to complex III. In the present study, the mechanisms involved in AMA-induced cell damage were investigated. Treatment of osteoblastic MC3T3-E1 cells with AMA decreased adenosine 3',5'-cyclic monophosphate (cAMP) level, activities of phosphoinositide 3-kinase (PI3K) and Akt (protein kinase B), and phosphorylated CREB (cAMP-response element-binding protein). To examine whether AMA-induced cell damage involves altered metabolism of pyridine nucleotides, the levels of NAD(+), NADH, NADP(+), and NADPH were measured. Treatment with AMA significantly decreased the levels of NAD(+) and NADPH. Moreover, the activities of aconitase and thioredoxin reductase were decreased by AMA treatment. These results suggest that PI3K/Akt/CREB pathway and pyridine nucleotide (NAD(+) and NADPH) are related to mitochondria function of osteoblasts.
Insights
Antimycin A damages osteoblasts by inhibiting mitochondrial electron transport. This leads to reduced pyridine nucleotides (NAD+ and NADPH) and impaired PI3K/Akt/CREB signaling, impacting osteoblast function.
Area of Science:
- Biochemistry
- Cell Biology
- Mitochondrial Biology
Background:
- Antimycin A (AMA) inhibits mitochondrial electron transport at complex III.
- Understanding AMA's cellular damage mechanisms is crucial for osteoblast health.
Purpose of the Study:
- To investigate the mechanisms underlying Antimycin A-induced cell damage in osteoblasts.
- To explore the role of pyridine nucleotides and the PI3K/Akt/CREB pathway in AMA's effects.
Main Methods:
- Treatment of MC3T3-E1 osteoblastic cells with Antimycin A.
- Measurement of cellular levels of adenosine 3',5'-cyclic monophosphate (cAMP), NAD+, NADH, NADP+, and NADPH.
- Assay of phosphoinositide 3-kinase (PI3K), Akt, phosphorylated CREB, aconitase, and thioredoxin reductase activities.
Main Results:
- AMA treatment decreased cAMP levels, PI3K, Akt, and phosphorylated CREB.
- AMA significantly reduced NAD+ and NADPH levels in osteoblasts.
- Activities of aconitase and thioredoxin reductase were diminished by AMA.
Conclusions:
- The PI3K/Akt/CREB pathway is implicated in Antimycin A-induced osteoblast damage.
- Pyridine nucleotides (NAD+ and NADPH) are involved in the mitochondrial dysfunction caused by AMA.
- AMA affects osteoblast mitochondrial function through these pathways.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

